newsfilter
← Latest News
ClinicalTrials.gov·

AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer - NCT05826015

Frequency and severity of treatment-related adverse events, Serum sAXL and GAS6 ratio, Pharmacokinetic (PK) parameters (including Cmax) as determined from AVB-500 serum levels, (and 5 more...)